Announcement of GUDID Release 2.2 Deployment and Document Updates


GUDID Release 2.2 was successfully deployed. The enhancements will allow for additional functionality as noted below.

  • Labelers will be able to “unlock” their device records after the DI record grace period to make error corrections. This will eliminate the need to contact the FDA UDI Help Desk to make corrections after the grace period.

Note that the Unlock functionality is intended to be used to correct data submission errors after the grace period. DO NOT USE Unlock functionality for edits that require assignment of a NEW Device Identifier. Please assign a new Device Identifier and submit a new record if you are changing data elements that are “New DI Triggers” (i.e., not correcting submission errors)

  • Addition of new data elements to the GUDID download file made available on AccessGUDID and OpenFDA to include –
  • Public Version Number
  • Public Version Date
  • Public Version Status (new/update/delete)
  • Public Device Record Key
  • Labeler DUNS Number
  • Premarket Submission Number & Supplement Number – note that this will be released after the testing/review period as indicated here.

GUDID documents (listed below) have been updated as of March 30, 2018.

We have also updated the GUDID System Enhancements and Fixes page to reflect all releases to-date.

If you have questions, concerns or feedback, please contact the FDA UDI Help Desk.


Related Resources

This course is an introduction to UDI (Unique Device Identifier) and the principal benefits of this system for health care delivery.
The Supply Chain Fundamentals eLearning series provides foundational skills for supply chain professionals. Participants will learn how to develop…
On-Demand Educational Webinars
#main-content p, #main-content ol>li, #main-content ul>li{ font-size:16px } .Banner_Tit
White Papers
Supply chain attributes inform critical supply availability and alignment with internal and external needs, integral to meeting pressures to deliver…
Consider the historical path of the Unique Device Identifier (UDI) currently hovering at its real-time usage and the resulting in cost savings and
The AHRMM LUC members submitted comments and recommendations to the FDA's Draft Guidance for Select Updates for Unique Device Identification: Policy…